Expert Perspectives on Advances in the Management of C. difficile - Episode 12
Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections
Implications for prescribing vancomycin or fidaxomicin to treat C. difficile infections.
Latest News
CDC Director Endorses ACIP Recommendation for Moderna COVID-19 Vaccine for Children and Adolescents
“Long COVID” Caused by High Levels of Virus-Specific T Cells
“Doing Quality Work, With Rigor”: Designing the Next Generation Pneumococcal Vaccine
CDC Identifies Adenovirus Infections in 45% of Acute Hepatitis Cases in Children